Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma.
Saved in:
| Title: | Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma. |
|---|---|
| Authors: | Palucka AK; Baylor Institute for Immunology Research, 3434 Live Oak, Dallas, Texas 75204, USA. karolinp@baylorhealth.edu, Dhodapkar MV, Paczesny S, Burkeholder S, Wittkowski KM, Steinman RM, Fay J, Banchereau J |
| Source: | Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2003 Sep-Oct; Vol. 26 (5), pp. 432-9. |
| Publication Type: | Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print Cited Medium: Print ISSN: 1524-9557 (Print) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
